ACRVVSBJDX• 6 Months (Normalized)
ACRV vs BJDX (Acrivon Therapeutics Inc. vs Bluejay Diagnostics Inc.)
Showing Closing Date Range from Mar, 20 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACRV Performance $1.7
+2.41%
Acrivon Therapeutics Inc.
Normalized Baseline0.00%
BJDX Performance $0.81
-59.75%
Bluejay Diagnostics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ACRV LEADS
+62.16%
ACRV outperforming by 62.16%
ACRVBJDX
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACRV BJDX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | ACRV Price | ACRV Gain (%) | BJDX Price | BJDX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.70 | +2.41% | $0.81 | -59.75% | +62.16% |
| Sep 15, 2026 | $1.83 | +10.24% | $0.85 | -58.02% | +68.26% |
| Sep 14, 2026 | $1.96 | +18.07% | $0.85 | -57.92% | +75.99% |
| Sep 11, 2026 | $2.00 | +20.48% | $0.90 | -55.59% | +76.07% |
| Sep 10, 2026 | $2.04 | +22.89% | $1.01 | -50.00% | +72.89% |
| Sep 09, 2026 | $1.99 | +19.88% | $1.01 | -50.00% | +69.88% |
| Sep 08, 2026 | $2.10 | +26.51% | $1.03 | -49.01% | +75.52% |
| Sep 04, 2026 | $2.13 | +28.31% | $0.83 | -58.81% | +87.12% |
| Sep 03, 2026 | $2.06 | +24.10% | $0.85 | -57.97% | +82.07% |
| Sep 02, 2026 | $2.15 | +29.52% | $0.85 | -57.97% | +87.49% |
| Sep 01, 2026 | $2.07 | +24.70% | $0.85 | -58.02% | +82.72% |
| Aug 31, 2026 | $2.09 | +25.90% | $0.87 | -56.93% | +82.83% |
| Aug 28, 2026 | $2.06 | +24.10% | $0.90 | -55.45% | +79.55% |
| Aug 27, 2026 | $2.15 | +29.52% | $0.91 | -54.95% | +84.47% |
| Aug 26, 2026 | $2.08 | +25.30% | $0.89 | -55.79% | +81.09% |
Page 1 of 9